178 related articles for article (PubMed ID: 870655)
41. Methotrexate-induced malabsorption in children with acute lymphoblastic leukaemia.
Craft AW; Kay H; Lawson DN; McElwain TJ
Br Med J; 1977 Dec; 2(6101):1511-2. PubMed ID: 271033
[TBL] [Abstract][Full Text] [Related]
42. Methotrexate-associated liver toxicity in a patient with breast cancer: case report and literature review.
van Outryve S; Schrijvers D; van den Brande J; Wilmes P; Bogers J; van Marck E; Vermorken JB
Neth J Med; 2002 Jun; 60(5):216-22. PubMed ID: 12365478
[TBL] [Abstract][Full Text] [Related]
43. Liver histology in patients receiving low dose pulse methotrexate for the treatment of rheumatoid arthritis.
Willkens RF; Leonard PA; Clegg DO; Tolman KG; Ward JR; Marks CR; Greene ML; Roth GJ; Jackson CG; Cannon GW
Ann Rheum Dis; 1990 Aug; 49(8):591-3. PubMed ID: 2396863
[TBL] [Abstract][Full Text] [Related]
44. Treatment of acute lymphoblastic leukemia in childreq with "prophylactic" intrathecal methotrexate and intensive systemic chemotherapy.
Haghbin M; Tan CT; Clarkson BD; Miké V; Burchenal JH; Murphy ML
Cancer Res; 1975 Mar; 35(3):807-11. PubMed ID: 1054287
[TBL] [Abstract][Full Text] [Related]
45. The value of dynamic hepatic scintigraphy and serum aminoterminal propeptide of type III procollagen for early detection of methotrexate-induced hepatic damage in psoriasis patients.
vanDooren-Greebe RJ; Kuijpers AL; Buijs WC; Kniest PH; Corstens FH; Nagengast FM; de Boo T; Willems JL; Duller P; van de Kerkhof PC
Br J Dermatol; 1996 Mar; 134(3):481-7. PubMed ID: 8731673
[TBL] [Abstract][Full Text] [Related]
46. Liver biopsy in methotrexate-treated psoriatics-a re-evalution.
Zachariae H; Grunnet E; Sogaard H
Acta Derm Venereol; 1975; 55(4):291-6. PubMed ID: 52258
[TBL] [Abstract][Full Text] [Related]
47. Busting the myth of methotrexate chronic hepatotoxicity.
Di Martino V; Verhoeven DW; Verhoeven F; Aubin F; Avouac J; Vuitton L; Lioté F; Thévenot T; Wendling D
Nat Rev Rheumatol; 2023 Feb; 19(2):96-110. PubMed ID: 36564450
[TBL] [Abstract][Full Text] [Related]
48. Oral methotrexate is as effective as intramuscular in maintenance therapy of acute lymphoblastic leukaemia.
Chessells JM; Leiper AD; Tiedemann K; Hardisty RM; Richards S
Arch Dis Child; 1987 Feb; 62(2):172-6. PubMed ID: 3469936
[TBL] [Abstract][Full Text] [Related]
49. Biomarkers for methotrexate-induced liver injury: urinary protein profiling of psoriasis patients.
van Swelm RP; Laarakkers CM; Kooijmans-Otero M; de Jong EM; Masereeuw R; Russel FG
Toxicol Lett; 2013 Aug; 221(3):219-24. PubMed ID: 23830989
[TBL] [Abstract][Full Text] [Related]
50. Intermediate dose methotrexate (IDM) in childhood acute lymphocytic leukemia in Norway. Preliminary results of a national treatment program.
Moe PJ; Seip M; Finne PH
Acta Paediatr Scand; 1981 Jan; 70(1):73-9. PubMed ID: 6971042
[No Abstract] [Full Text] [Related]
51. Hepatocellular carcinoma in a long-term survivor of acute lymphocytic leukemia.
Fried M; Kalra J; Ilardi CF; Sawitsky A
Cancer; 1987 Nov; 60(10):2548-52. PubMed ID: 2444327
[TBL] [Abstract][Full Text] [Related]
52. [Laboratory and oligobiopsy examination of the liver in patients with psoriasis treated with methotrexate (preliminary report)].
Ruszczak Z; Prószyńska-Kuczyńska W; Babiński S; Biernat S; Kulig A
Przegl Dermatol; 1974; 61(6):803-7. PubMed ID: 4431967
[No Abstract] [Full Text] [Related]
53. [Acute hepatotoxicity with intermediate-dose methotrexate in children with leukemia and non-Hodgkin's lymphoma].
Exadaktylos P; Reiss T; Schobess R; Hommann M; Höhne S; Beck A
Klin Padiatr; 1994; 206(4):315-8. PubMed ID: 7967431
[TBL] [Abstract][Full Text] [Related]
54. Liver damage in children with acute leukaemia and non-Hodgkin's lymphoma on oral maintenance chemotherapy.
Parker D; Bate CM; Craft AW; Graham-Pole J; Malpas JS; Stansfeld AG
Cancer Chemother Pharmacol; 1980; 4(2):121-7. PubMed ID: 6930333
[TBL] [Abstract][Full Text] [Related]
55. Use of methotrexate in psoriasis.
Roenigk HH; Maibach HI; Weinstein GD
Arch Dermatol; 1972 Mar; 105(3):363-5. PubMed ID: 5012144
[No Abstract] [Full Text] [Related]
56. Liver disease in psoriatics--An effect of methotrexate therapy?
Shapiro HA; Trowbridge JO; Lee JC; Maibach HI
Arch Dermatol; 1974 Oct; 110(4):547-51. PubMed ID: 4414499
[No Abstract] [Full Text] [Related]
57. Hepatotoxicity and accelerated fibrosis following 3,4-methylenedioxymetamphetamine ("ecstasy") usage.
Khakoo SI; Coles CJ; Armstrong JS; Barry RE
J Clin Gastroenterol; 1995 Apr; 20(3):244-7. PubMed ID: 7797836
[TBL] [Abstract][Full Text] [Related]
58. Methotrexate induced hepatitis in childhood leukemia.
Taft LI
Isr J Med Sci; 1965 Jul; 1(4):823-7. PubMed ID: 5856123
[No Abstract] [Full Text] [Related]
59. Treatment of dermatomyositis with methotrexate.
Zieglschmid-Adams ME; Pandya AG; Cohen SB; Sontheimer RD
J Am Acad Dermatol; 1995 May; 32(5 Pt 1):754-7. PubMed ID: 7722021
[TBL] [Abstract][Full Text] [Related]
60. Liver biopsies in patients on methotrexate for the treatment of psoriasis.
Callen JP; Hanno R
Int J Dermatol; 1980 May; 19(4):215. PubMed ID: 7399793
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
